DERYNCOCH CYF
Company number 14459022 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
DERYNCOCH CYF - Analysis Report
Company Number: 14459022
Analysis Date: 2025-07-29 12:43 UTC
Financial Health Assessment for DERYNCOCH CYF
Date of Evaluation: June 2024
1. Financial Health Score: B
Explanation:
DERYNCOCH CYF demonstrates a stable financial footing typical of a newly incorporated micro-entity. The company has solid net current assets with no reported liabilities, indicating a healthy liquidity position. However, the absence of revenue, profit, or more detailed financial data limits a full evaluation. Given this, the score reflects a sound but early-stage financial condition with some caution due to limited operational history.
2. Key Vital Signs
| Metric | Value | Interpretation |
|---|---|---|
| Company Size | Micro | Smallest account category, minimal filing requirements; typical for a young company |
| Net Current Assets | £8,240 | Positive working capital, indicating ability to cover short-term obligations comfortably |
| Current Liabilities | £0 | No short-term debts, reducing financial pressure |
| Shareholders’ Funds (Equity) | £8,240 | Total equity matches net assets, indicating no external debt and funds fully owned by shareholders |
| Average Number of Employees | 2 | Very small workforce, inline with micro-entity status |
| Filing Status | Up to date | No overdue accounts or confirmation statements, reflecting compliance and good governance |
| Industry | Support activities to performing arts; Management consultancy | Sectors often dependent on project-based income, requiring careful cash flow management |
Interpretation:
The company shows the vital signs of a “healthy heartbeat” with positive equity and no liabilities. The absence of debt is a strong indicator of low financial stress. The micro-entity status and small employee base suggest the company is in an early development phase, possibly pre-revenue or with low turnover, which is typical for a company incorporated recently (Nov 2022).
3. Diagnosis
Symptoms Analysis:
- Healthy cash flow position: The positive net current assets and zero liabilities indicate no current symptoms of financial distress such as overdue payments or reliance on creditor financing.
- Early-stage growth profile: The small asset base and workforce are consistent with a company in start-up or early operational phase. The lack of detailed income or profit figures suggests the business is likely still establishing itself or operating with minimal transactions.
- Strong ownership control: Two directors hold significant control (25-50% shares and voting rights each), implying stable governance but potentially concentrated decision-making.
- Industry risks: Operating in performing arts support and management consultancy can be volatile and project-dependent, requiring careful cash and resource management.
Overall Diagnosis:
DERYNCOCH CYF appears financially sound and well-positioned for its stage, with no immediate signs of distress. Its financial "vital signs" indicate a stable, low-risk profile but with the typical constraints of limited scale and operational history. The absence of liabilities and positive equity is reassuring, but the company must continue to monitor cash flows closely as it grows.
4. Recommendations
Develop Cash Flow Forecasting:
Establish regular cash flow projections to anticipate funding needs due to the project-based nature of the business. This will help detect any early "symptoms" of liquidity strain.Build Revenue and Profit Tracking:
Start detailed tracking of revenue streams and profitability to better understand income drivers and cost pressures. This will help transition from a start-up phase to sustainable operations.Consider Diversifying Funding Sources:
Although currently debt-free, exploring modest financing options or grants could provide a buffer to support growth and manage cash flow timing gaps.Governance and Succession Planning:
With significant control concentrated in two shareholders/directors, consider formalizing governance structures and succession plans to mitigate risks related to key person dependency.Regular Financial Review:
Schedule quarterly financial health reviews, including analysis of working capital, to catch any early warning signs and maintain financial wellness.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.